FYB203, a biosimilar to aflibercept, received UK MHRA approval for multiple retinal conditions and will be marketed as ...

The ASO has appointed three new board members to enhance advocacy and efficiency within the organization. Rahul Chakrabarti ...

The state-of-the-art facility more than doubles the institute’s footprint, enhancing patient care, research, and education.

Alcon announced the US launch of SYSTANE PRO Preservative-Free (PF) as part of the company’s dry eye products. The ...

Combining eyelid pressure patching with AMT effectively heals persistent corneal epithelial defects, offering rapid ...

A PDUFA date has been set for October 20, 2025. If approved, Epoxia will be the first epi-on corneal crosslinking on the market.

Luxa Biotechnology LLC announced that the US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced ...

At the Envision Summit 2025 in San Juan, Puerto Rico, retina program chairs Geeta Lalwani, MD, and Majda Hadziahmetovic, MD, ...

Telomir Pharmaceuticals shared results from its recent preclinical studies conducted in human retinal cell lines and plans ...

Direct selective laser trabeculoplasty enhances the experience for both patients and physicians, he notes, while also ...

At the Envision Summit 2025 in San Juan, Puerto Rico, Mike Farkas, MD, discussed gene therapy research for retinal ...